Trade GeoVax Labs, Inc. - GOVX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.0052 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 0.4 |
| Open* | 0.3987 |
| 1-Year Change* | -49.69% |
| Day's Range* | 0.3867 - 0.3987 |
| 52 wk Range | 0.47-1.39 |
| Average Volume (10 days) | 90.28K |
| Average Volume (3 months) | 4.89M |
| Market Cap | 13.88M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 26.70M |
| Revenue | N/A |
| EPS | -0.90 |
| Dividend (Yield %) | N/A |
| Beta | 2.89 |
| Next Earnings Date | Mar 21, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 5, 2023 | 0.3887 | -0.0131 | -3.26% | 0.4018 | 0.4018 | 0.3827 |
| Dec 4, 2023 | 0.4000 | 0.0013 | 0.33% | 0.3987 | 0.4038 | 0.3797 |
| Dec 1, 2023 | 0.4037 | -0.0150 | -3.58% | 0.4187 | 0.4267 | 0.4000 |
| Nov 30, 2023 | 0.4187 | -0.0100 | -2.33% | 0.4287 | 0.4307 | 0.4087 |
| Nov 29, 2023 | 0.4287 | -0.0231 | -5.11% | 0.4518 | 0.4536 | 0.4087 |
| Nov 28, 2023 | 0.4487 | 0.0200 | 4.67% | 0.4287 | 0.4875 | 0.4287 |
| Nov 27, 2023 | 0.4337 | -0.0441 | -9.23% | 0.4778 | 0.4877 | 0.4212 |
| Nov 24, 2023 | 0.4787 | -0.0310 | -6.08% | 0.5097 | 0.5130 | 0.4787 |
| Nov 22, 2023 | 0.5098 | -0.0059 | -1.14% | 0.5157 | 0.5187 | 0.5097 |
| Nov 21, 2023 | 0.5187 | -0.0130 | -2.44% | 0.5317 | 0.5318 | 0.5187 |
| Nov 20, 2023 | 0.5317 | -0.0070 | -1.30% | 0.5387 | 0.5487 | 0.5287 |
| Nov 17, 2023 | 0.5387 | 0.0200 | 3.86% | 0.5187 | 0.5588 | 0.5117 |
| Nov 16, 2023 | 0.5388 | -0.0019 | -0.35% | 0.5407 | 0.5408 | 0.5187 |
| Nov 15, 2023 | 0.5422 | 0.0035 | 0.65% | 0.5387 | 0.5422 | 0.5287 |
| Nov 14, 2023 | 0.5334 | -0.0053 | -0.98% | 0.5387 | 0.5588 | 0.5293 |
| Nov 13, 2023 | 0.5438 | 0.0151 | 2.86% | 0.5287 | 0.5439 | 0.5178 |
| Nov 10, 2023 | 0.5287 | 0.0066 | 1.26% | 0.5221 | 0.5357 | 0.4987 |
| Nov 9, 2023 | 0.5356 | 0.0169 | 3.26% | 0.5187 | 0.5382 | 0.5187 |
| Nov 8, 2023 | 0.5457 | 0.0270 | 5.21% | 0.5187 | 0.5457 | 0.5157 |
| Nov 7, 2023 | 0.5281 | 0.0094 | 1.81% | 0.5187 | 0.5378 | 0.5187 |
GeoVax Labs, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, December 6, 2023 | ||
| Time (UTC) 20:25 | Country US
| Event GeoVax Labs Inc at Emerging Growth Conference GeoVax Labs Inc at Emerging Growth ConferenceForecast -Previous - |
| Thursday, March 21, 2024 | ||
| Time (UTC) 10:59 | Country US
| Event Q4 2023 GeoVax Labs Inc Earnings Release Q4 2023 GeoVax Labs Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 0.08153 | 0.3855 | 1.82366 | 1.1759 | 0.9632 |
| Revenue | 0.08153 | 0.3855 | 1.82366 | 1.1759 | 0.9632 |
| Total Operating Expense | 14.1101 | 18.9593 | 4.64047 | 3.54839 | 3.52592 |
| Selling/General/Admin. Expenses, Total | 4.98661 | 3.57715 | 2.19601 | 1.63767 | 1.64727 |
| Research & Development | 9.12348 | 15.5542 | 2.44446 | 1.91072 | 1.87865 |
| Operating Income | -14.0286 | -18.5738 | -2.81681 | -2.37249 | -2.56272 |
| Interest Income (Expense), Net Non-Operating | 0.00744 | 0.00345 | -0.14125 | 0.00186 | 0.00262 |
| Net Income Before Taxes | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Net Income After Taxes | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Net Income Before Extra. Items | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Net Income | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Income Available to Common Excl. Extra. Items | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Income Available to Common Incl. Extra. Items | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Diluted Net Income | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Diluted Weighted Average Shares | 16.9732 | 6.09993 | 1.38383 | 0.00302 | 0.00001 |
| Diluted EPS Excluding Extraordinary Items | -0.82607 | -3.04435 | -2.1376 | -784.951 | -312999 |
| Diluted Normalized EPS | -0.82607 | -3.07255 | -2.1376 | -784.951 | -312999 |
| Total Extraordinary Items | |||||
| Unusual Expense (Income) | 0 | -0.17206 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Total Operating Expense | 6.17882 | 4.27061 | 5.3875 | 3.97053 | 2.24249 |
| Selling/General/Admin. Expenses, Total | 1.45909 | 1.45143 | 1.62294 | 1.24934 | 0.93531 |
| Research & Development | 4.71973 | 2.81919 | 3.76456 | 2.7212 | 1.30718 |
| Operating Income | -6.17882 | -4.27061 | -5.3875 | -3.97053 | -2.24249 |
| Interest Income (Expense), Net Non-Operating | 0.2512 | 0.2327 | 0.00369 | 0.00243 | 0.00079 |
| Net Income Before Taxes | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Net Income After Taxes | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Net Income Before Extra. Items | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Net Income | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Income Available to Common Excl. Extra. Items | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Income Available to Common Incl. Extra. Items | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Diluted Net Income | -5.92762 | -4.03792 | -5.38381 | -3.9681 | -2.2417 |
| Diluted Weighted Average Shares | 26.4436 | 26.3386 | 26.4378 | 23.4617 | 12.7217 |
| Diluted EPS Excluding Extraordinary Items | -0.22416 | -0.15331 | -0.20364 | -0.16913 | -0.17621 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.22416 | -0.15331 | -0.20364 | -0.16913 | -0.17621 |
| Unusual Expense (Income) | 0 | 0 | 0 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 28.9387 | 11.6291 | 10.2352 | 0.44726 | 0.6197 |
| Cash and Short Term Investments | 27.6127 | 11.4239 | 9.8838 | 0.28334 | 0.2597 |
| Cash & Equivalents | 27.6127 | 11.4239 | 9.8838 | 0.28334 | 0.2597 |
| Total Receivables, Net | 0 | 0.04901 | 0.18266 | 0.0686 | 0.12181 |
| Accounts Receivable - Trade, Net | 0 | 0.04901 | 0.18266 | 0.0686 | 0.12181 |
| Prepaid Expenses | 1.326 | 0.15624 | 0.16869 | 0.09532 | 0.23819 |
| Total Assets | 31.3479 | 11.7971 | 10.3939 | 0.46888 | 0.64206 |
| Property/Plant/Equipment, Total - Net | 0.23491 | 0.15694 | 0.14774 | 0.01061 | 0.01135 |
| Other Long Term Assets, Total | 2.17429 | 0.01101 | 0.01101 | 0.01101 | 0.01101 |
| Total Current Liabilities | 4.74789 | 5.43536 | 0.81031 | 2.01619 | 1.62483 |
| Accounts Payable | 1.74768 | 2.05753 | 0.2677 | 0.15265 | 0.12586 |
| Accrued Expenses | 3.00021 | 3.37783 | 0.35928 | 1.85104 | 1.23855 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 4.74789 | 7.43536 | 0.82505 | 2.04344 | 1.66441 |
| Total Long Term Debt | 0 | 0 | 0.01474 | 0.02724 | 0.03958 |
| Total Equity | 26.6 | 4.3617 | 9.56885 | -1.57456 | -1.02235 |
| Preferred Stock - Non Redeemable, Net | 0 | 0.0761 | 1.93243 | 1.97133 | |
| Common Stock | 0.02634 | 0.00638 | 0.00383 | 0.0003 | 0.2189 |
| Additional Paid-In Capital | 104.971 | 68.7312 | 55.2945 | 39.3402 | 37.2643 |
| Retained Earnings (Accumulated Deficit) | -78.397 | -64.3759 | -45.8056 | -42.8475 | -40.4769 |
| Total Liabilities & Shareholders’ Equity | 31.3479 | 11.7971 | 10.3939 | 0.46888 | 0.64206 |
| Total Common Shares Outstanding | 26.3349 | 6.38154 | 3.8341 | 0.01499 | 0.00001 |
| Total Preferred Shares Outstanding | 0 | 0.0002 | 0.00427 | 0.00345 | |
| Property/Plant/Equipment, Total - Gross | 0.84142 | 0.70716 | 0.6746 | ||
| Accumulated Depreciation, Total | -0.60651 | -0.55022 | -0.66325 | ||
| Current Port. of LT Debt/Capital Leases | 0 | 0.18333 | 0.0125 | 0.26042 | |
| Long Term Debt | 0 | 0.01474 | 0.02724 | 0.03958 | |
| Other Liabilities, Total | 0 | 2 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 14.8003 | 19.8272 | 25.9888 | 28.9387 | 36.1372 |
| Cash and Short Term Investments | 12.687 | 17.7889 | 23.8499 | 27.6127 | 34.677 |
| Cash & Equivalents | 12.687 | 17.7889 | 23.8499 | 27.6127 | 34.677 |
| Total Receivables, Net | 0 | 0 | |||
| Accounts Receivable - Trade, Net | 0 | 0 | |||
| Prepaid Expenses | 2.11325 | 2.03828 | 2.13897 | 1.326 | 1.46021 |
| Total Assets | 16.201 | 21.2491 | 27.4042 | 31.3479 | 38.5704 |
| Property/Plant/Equipment, Total - Net | 0.21295 | 0.22408 | 0.21759 | 0.23491 | 0.24898 |
| Property/Plant/Equipment, Total - Gross | 0.87141 | 0.86522 | 0.84142 | 0.84142 | 0.84142 |
| Accumulated Depreciation, Total | -0.65846 | -0.64114 | -0.62382 | -0.60651 | -0.59243 |
| Other Long Term Assets, Total | 1.18779 | 1.19779 | 1.19779 | 2.17429 | 2.18429 |
| Total Current Liabilities | 7.08169 | 4.08551 | 4.53906 | 4.74789 | 4.78941 |
| Accounts Payable | 4.2133 | 0.87113 | 1.288 | 1.74768 | 1.07942 |
| Accrued Expenses | 2.86839 | 3.21438 | 3.25106 | 3.00021 | 3.70998 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Total Liabilities | 7.08169 | 4.08551 | 4.53906 | 4.74789 | 6.78941 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Total Equity | 9.11935 | 17.1635 | 22.8652 | 26.6 | 31.781 |
| Preferred Stock - Non Redeemable, Net | |||||
| Common Stock | 0.0267 | 0.02644 | 0.02644 | 0.02634 | 0.02634 |
| Additional Paid-In Capital | 105.864 | 105.5 | 105.274 | 104.971 | 104.768 |
| Retained Earnings (Accumulated Deficit) | -96.7714 | -88.3626 | -82.4349 | -78.397 | -73.0132 |
| Total Liabilities & Shareholders’ Equity | 16.201 | 21.2491 | 27.4042 | 31.3479 | 38.5704 |
| Total Common Shares Outstanding | 26.6953 | 26.4436 | 26.4436 | 26.3349 | 26.3349 |
| Total Preferred Shares Outstanding | |||||
| Other Liabilities, Total | 0 | 2 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -14.0211 | -18.5703 | -2.95807 | -2.37063 | -2.56009 |
| Cash From Operating Activities | -19.0302 | -11.1964 | -2.75057 | -1.3985 | -1.54303 |
| Cash From Operating Activities | 0.05628 | 0.03852 | 0.01966 | 0.00835 | 0.0198 |
| Non-Cash Items | 0.90207 | 0.40776 | 0.18865 | 0.3275 | 0.46972 |
| Changes in Working Capital | -5.96744 | 6.92762 | -0.00081 | 0.63628 | 0.52754 |
| Cash From Investing Activities | -0.13426 | -0.04772 | -0.15679 | -0.00761 | 0 |
| Capital Expenditures | -0.13426 | -0.04772 | -0.15679 | -0.00761 | 0 |
| Cash From Financing Activities | 35.3533 | 12.7842 | 12.5078 | 1.42974 | 1.49 |
| Issuance (Retirement) of Stock, Net | 35.3533 | 12.8121 | 11.461 | 1.44 | 1.19 |
| Net Change in Cash | 16.1889 | 1.54007 | 9.60046 | 0.02364 | -0.05303 |
| Issuance (Retirement) of Debt, Net | 0 | -0.02786 | 1.04682 | -0.01026 | 0.3 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -4.03792 | -14.0211 | -8.63732 | -4.66921 | -2.42752 |
| Cash From Operating Activities | -3.76287 | -19.0302 | -11.966 | -8.16682 | -4.33324 |
| Cash From Operating Activities | 0.01732 | 0.05628 | 0.04221 | 0.02454 | 0.01227 |
| Non-Cash Items | 0.24604 | 0.90207 | 0.6509 | 0.41233 | 0.20515 |
| Changes in Working Capital | 0.01169 | -5.96744 | -4.02176 | -3.93447 | -2.12315 |
| Cash From Investing Activities | 0 | -0.13426 | -0.13426 | -0.08238 | -0.06219 |
| Capital Expenditures | 0 | -0.13426 | -0.13426 | -0.08238 | -0.06219 |
| Cash From Financing Activities | 0 | 35.3533 | 35.3533 | 27.7278 | 9.22927 |
| Issuance (Retirement) of Stock, Net | 0 | 35.3533 | 35.3533 | 27.7278 | 9.22927 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
| Net Change in Cash | -3.76287 | 16.1889 | 23.2531 | 19.4786 | 4.83385 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.7643 | 730985 | 0 | 2023-06-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.5635 | 413444 | 0 | 2023-06-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6533 | 172750 | 0 | 2023-06-30 | LOW |
| Dodd (David A) | Individual Investor | 0.5633 | 148957 | 35087 | 2023-08-25 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3704 | 97942 | 0 | 2023-06-30 | LOW |
| Reynolds (Mark W) | Individual Investor | 0.2957 | 78184 | 10000 | 2023-08-18 | LOW |
| McNally (Robert T) | Individual Investor | 0.2039 | 53925 | 0 | 2023-06-02 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.1898 | 50197 | 0 | 2023-06-30 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 0.1392 | 36805 | 20716 | 2023-06-30 | HIGH |
| Chase (Randal D) | Individual Investor | 0.1385 | 36613 | 0 | 2023-06-02 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1294 | 34214 | 0 | 2023-06-30 | LOW |
| McKee (Kelly T Jr.) | Individual Investor | 0.1091 | 28838 | 9653 | 2023-09-25 | |
| Virtu Americas LLC | Research Firm | 0.1025 | 27097 | 27097 | 2023-06-30 | HIGH |
| Spencer (John N Jr) | Individual Investor | 0.0795 | 21024 | 0 | 2023-06-02 | |
| Welch & Forbes LLC | Investment Advisor/Hedge Fund | 0.0643 | 16994 | 0 | 2023-06-30 | LOW |
| Kollintzas (Dean G) | Individual Investor | 0.0453 | 11987 | 0 | 2023-06-02 | LOW |
| GSA Capital Partners LLP | Hedge Fund | 0.0428 | 11328 | 11328 | 2023-06-30 | HIGH |
| Tower Research Capital LLC | Hedge Fund | 0.0399 | 10562 | -194 | 2023-06-30 | HIGH |
| Wells Fargo Advisors | Research Firm | 0.017 | 4500 | 120 | 2023-06-30 | LOW |
| Osaic Holdings, Inc. | Investment Advisor | 0.0113 | 3000 | 0 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
GeoVax Labs, Inc. Company profile
About Geovax Labs Inc
GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and cancer using its platforms. Its product pipeline includes ongoing human clinical trials for COVID-19 and head and neck cancer. The Company is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. The Company’s product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02, GEO-EM01, GEO-LM01 and GEO-MM02. Its research and development programs include preventive vaccines against Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa) and malaria, as well as immunotherapies for multiple solid tumors. The Company’s wholly owned subsidiaries include GeoVax, Inc. and Immutak Oncology, Inc.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Geovax Labs Inc revenues decreased 79% to $386K. Net loss increased from $3M to $18.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development increase from $2.4M to $15.6M (expense), General and administrative increase of 63% to $3.6M (expense).
Equity composition
Common Stock $.001 Par, 04/11, 40M auth., 15,699,909 issd. Insiders control approx. 39.31%. IPO: NA. Private Placement: 1997, 4.4M shares @ $1. 9/06, Co. acq. by GeoVax, Inc. & name changed from Dauphin Technology, Inc. 04/10, 1-for-50 reverse split.
| Industry: | Biotechnology & Medical Research (NEC) |
1900 Lake Park Drive
Suite 380
SMYRNA
GEORGIA 30080
US
Income Statement
- Annual
- Quarterly
News
December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com